Skip to content

13F-HR filed by DAFNA Capital Management LLC

DAFNA Capital Management LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 75 holding rows worth $205,558,000.

Accession
0001389933-18-000008
Filed
2018-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 75 entries on the cover page, a total value of $205,558,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $205,558,000 with VALUE read as thousands by filing date, 13F file number 028-12327. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
LOXO ONCOLOGY INC548862101COM181,537$20,944,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM94,000$15,141,000thousands by filing date
STEREOTAXIS INC85916J409COMMON STOCK13,680,554$9,096,000thousands by filing date
BLUEPRINT MEDICINES CORP09627Y109COM88,691$8,133,000thousands by filing date
ATRICURE INC04963C209COM389,145$7,985,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK306,119$7,610,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM132,770$7,203,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK610,738$5,820,000thousands by filing date
DEXCOM INC COM252131107Stock75,000$5,562,000thousands by filing date
ASCENDIS PHARMA A/S DKK 1.0 AD04351P101SPONSORED ADR79,245$5,183,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339105COM396,013$5,029,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW126,742$5,006,000thousands by filing date
LUMINEX CORP55027E102COMMON STOCK227,500$4,793,000thousands by filing date
ARGENX SE SPONSORED ADR04016X101ADR58,130$4,676,000thousands by filing date
BIOCRYST PHARMACEUTICALS INC COM09058V103Stock974,652$4,649,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM54,508$4,520,000thousands by filing date
CYMABAY THERAPEUTICS INC23257D103COM323,843$4,207,000thousands by filing date
IMMUNOMEDICS INC452907108COM280,900$4,104,000thousands by filing date
RADIUS HEALTH INC750469AA6NOTE4,000,000$4,000,000thousands by filing dateprincipal
LAKEFRONT BIOTHERAPEUTICS NV36315X101SPON ADR39,609$3,951,000thousands by filing date
ZOGENIX INC.98978L204Common Stock94,264$3,775,000thousands by filing date
VBI VACCINES INC91822J103COM NEW998,000$3,493,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM868,272$3,221,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK901,933$3,193,000thousands by filing date
INSULET CORP COM45784P101Stock32,484$2,816,000thousands by filing date
ISHARES TR464287556ISHARES BIOTECH26,100$2,786,000thousands by filing date
KURA ONCOLOGY INC COM50127T109Stock127,000$2,381,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock1,636,900$2,193,000thousands by filing date
BIOTELEMETRY INC090672106COM69,500$2,158,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365AAB7NOTE 4.500% 9/12,500,000$2,125,000thousands by filing dateprincipal
MACROGENICS INC556099109COM83,105$2,091,000thousands by filing date
XENON PHARMACEUTICALS INC COM98420N105Stock377,695$1,851,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock44,400$1,780,000thousands by filing date
FOAMIX PHARMACEUTICALS LTDM46135105SHS335,500$1,721,000thousands by filing date
INSULET CORP45784PAG6NOTE 1.375%1,500,000$1,711,000thousands by filing dateprincipal
LEAP THERAPEUTICS INC52187K101COM200,000$1,660,000thousands by filing date
APPLIED GENETIC TECHNOL CORP03820J100COM421,000$1,621,000thousands by filing date
CLEMENTIA PHARMACEUTICALS IN185575107COM105,000$1,591,000thousands by filing date
AQUINOX PHARMACEUTICALS INC03842B101COM107,928$1,520,000thousands by filing date
ARQULE INC04269E107COM484,984$1,397,000thousands by filing date
NATUS MEDICAL INC639050103COM37,900$1,275,000thousands by filing date
PROTEOSTASIS THERAPEUTICS IN74373B109COM267,100$1,269,000thousands by filing date
ARDELYX INC039697107COM247,859$1,252,000thousands by filing date
INCYTE CORP COM45337C102Stock15,000$1,250,000thousands by filing date
BEONE MEDICINES LTD SPONSORED ADS07725L102ADR7,330$1,231,000thousands by filing date
Johnson & Johnson478160104COM9,400$1,205,000thousands by filing date
COGENTIX MED INC COM19243A104Stock310,382$1,195,000thousands by filing date
DERMIRA INC24983LAA2NOTE 3.000% 5/11,500,000$1,192,000thousands by filing dateprincipal
ADVAXIS INC007624208COM NEW697,000$1,178,000thousands by filing date
CARA THERAPEUTICS INC140755109COM93,800$1,161,000thousands by filing date
IMMUNE DESIGN CORP.45252L103Common Stock328,500$1,084,000thousands by filing date
MINERVA NEUROSCIENCES INC COM NEW603380106Stock171,094$1,069,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328700COM373,702$1,016,000thousands by filing date
PROQR THERAPEUTICS NVN71542109SHS EURO230,770$710,000thousands by filing date
SCPHARMACEUTICALS INC810648105COM55,844$692,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333XAD0DBCV 2.250% 6/1573,000$676,000thousands by filing dateprincipal
GEMPHIRE THERAPEUTICS INC36870A108COM100,000$651,000thousands by filing date
DERMIRA INC24983L104COM76,000$607,000thousands by filing date
INOTEK PHARMACEUTICALS CORP45780VAB8NOTE 5.750% 8/0600,000$578,000thousands by filing dateprincipal
Bowater Inc09066L105COMMON STOCKS181,600$489,000thousands by filing date
MASIMO CORP COM574795100Stock5,000$440,000thousands by filing date
SPERO THERAPEUTICS INC84833T103COM29,544$421,000thousands by filing date
SOL GEL TECHNOLOGIESM8694L103SHS35,000$361,000thousands by filing date
TANDEM DIABETES CARE INC875372203COM NEW60,000$298,000thousands by filing date
DEXCOM INC252131AE7DBCV 0.750% 5/1250,000$256,000thousands by filing dateprincipal
NEOS THERAPEUTICS INC64052L106COM27,500$228,000thousands by filing date
ALDER BIOPHARMACEUTICALS INC014339AA3NOTE 2.500% 2/0250,000$227,000thousands by filing dateprincipal
UROGEN PHARMA LTDM96088105COMMON STOCK4,500$224,000thousands by filing date
SIERRA ONCOLOGY INC82640U107COM79,969$166,000thousands by filing date
ARCUS BIOSCIENCES INC03969F109COM7,500$116,000thousands by filing date
CIDARA THERAPEUTICS INC COM NEW171757107Stock23,132$93,000thousands by filing date
ObsEva SAH5861P103COM6,785$92,000thousands by filing date
COGENT BIOSCIENCES INC COM903214104COM7,900$88,000thousands by filing date
CLEARSIDE BIOMEDICAL INC185063104COM5,000$54,000thousands by filing date
BIONDVAX PHARMACEUTICALS LTD09073Q105SPOND ADS3,399$18,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001389933-18-000008this filing2018-05-15acceptance time not in the bulk data set